Presidio Property Trust Inc Preferred Series D

NASDAQ SQFTP

Download Data

Presidio Property Trust Inc Preferred Series D EBIT to Total Assets Ratio 3 year CAGR for the quarter ending March 31, 2024

Presidio Property Trust Inc Preferred Series D EBIT to Total Assets Ratio 3 year CAGR is NA for the quarter ending March 31, 2024. The EBIT to Total Assets Ratio measures a company's operating earnings (EBIT) generated per dollar of total assets. It shows how efficiently a company utilizes its assets to generate earnings. A higher ratio indicates better asset utilization and profitability. It reflects the ability of a company to generate earnings from its invested assets and is useful in assessing operational efficiency and financial performance. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Presidio Property Trust Inc Preferred Series D EBIT to Total Assets Ratio for the quarter ending March 31, 2023 was -0.00.
NASDAQ: SQFTP

Presidio Property Trust Inc Preferred Series D

CEO -
IPO Date June 11, 2021
Location United States
Headquarters 4995 Murphy Canyon Road, San Diego, CA, United States, 92123
Employees 15
Sector Real Estate
Industry Reit - diversified
Description

Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.

Similar companies

ATLCP

Atlanticus Holdings Corp Preferred

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email